Silenseed Competitors and Similar CompaniesClear all
Silenseed's competitors and similar companies include Nektar Therapeutics and Puma Biotechnology.
 Silenseed Silenseed is a biopharmaceutical company developing RNA interference (RNAi)-based cancer drugs. |  Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. | ||
Founding Date | Founding Date 1999 | Founding Date 1990 | Founding Date 2010 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Modi'in-Maccabim-Re'ut, IL HQ | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Los Angeles, US HQ |
Employees | Employees 4 | Employees 61821% increase | Employees 27214% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 233.8 m | Valuation ($) 136.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) $228.4m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 10.5m | Total funding raised $ 45m | Total funding raised $ 172m |
For sources of this data, please see the company profile
View Company Profiles
Nektar Therapeutics
HQ
San Francisco, US
Employees
618↑ 21% increase
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View companyPuma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View company